Sort   by:  
 Page size 
MetabolomicsDT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates

Nonalcoholic steatohepatitis (NASH) prevalence is rising with no pharmacotherapy approved. A major hurdle in NASH drug development is the poor translatability of preclinical studies to safe/effective clinical outcomes, and recent failures highlight a need to identify new targetable pathways. Dysr...

2023-04-13 | MTBLS5005 | MetaboLights
ProteomicsProteogenomic characterization of human colon and rectal cancer
Explore This Study at the NCI Proteomic Data Commons

Zhang, B., et al., Nature (2014) do...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2019-08-26 | MSV000084238 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 8
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080168 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 3
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080159 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 4
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080160 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 7
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080163 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 5
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080161 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 6
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080162 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 2
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080158 | MassIVE
ProteomicsCPTAC, TCGA Cancer Proteome Study of Colorectal Tissue: Proteome, VU, part 9
The goal of the CPTAC, TCGA Cancer Proteome Study of Colorectal Tissue is to analyze the proteomes of TCGA tumor samples that have been comprehensively characterized by molecular methods. Ninety-five TCGA tumor samples were used in this study.
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
MSV000080169 | MassIVE
Sort   by:  
 Page size